DGP-GeneSGKit®

Sistemas Genómicos, a member of the biomedical group ASCIRES, has designed the DGP-GeneSGKit®, the most thorough and sensitive test on the market for detecting aneuploidies, chromosomal segments and unbalanced structural chromosome rearrangements and CNVs based on blastomere and trophectoderm samples for next-generation sequencing (NGS) platforms*.

DGP-GeneSGKit® enables chromosome abnormalities and aneuploidies to be detected with a limit of detection of 20 Mb in human embryos prior to implantation, based on blastomere or  trophectoderm samples using low-coverage whole-genome sequencing.